Literature DB >> 19815722

Genotype analysis identifies the cause of the "royal disease".

Evgeny I Rogaev1, Anastasia P Grigorenko, Gulnaz Faskhutdinova, Ellen L W Kittler, Yuri K Moliaka.   

Abstract

The "royal disease," a blood disorder transmitted from Queen Victoria to European royal families, is a striking example of X-linked recessive inheritance. Although the disease is widely recognized to be a form of the blood clotting disorder hemophilia, its molecular basis has never been identified, and the royal disease is now likely extinct. We identified the likely disease-causing mutation by applying genomic methodologies (multiplex target amplification and massively parallel sequencing) to historical specimens from the Romanov branch of the royal family. The mutation occurs in F9, a gene on the X chromosome that encodes blood coagulation factor IX, and is predicted to alter RNA splicing and to lead to production of a truncated form of factor IX. Thus, the royal disease is the severe form of hemophilia, also known as hemophilia B or Christmas disease.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19815722     DOI: 10.1126/science.1180660

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  23 in total

1.  Genes and queens.

Authors:  Mark A Jobling
Journal:  Investig Genet       Date:  2011-06-01

2.  High-throughput molecular diagnosis of von Willebrand disease by next generation sequencing methods.

Authors:  Irene Corrales; Susana Catarino; Júlia Ayats; David Arteta; Carmen Altisent; Rafael Parra; Francisco Vidal
Journal:  Haematologica       Date:  2012-02-07       Impact factor: 9.941

3.  Gene therapy for hemophilia: the clot thickens.

Authors:  Katherine A High
Journal:  Hum Gene Ther       Date:  2014-11       Impact factor: 5.695

4.  Born in the blood.

Authors:  Neil Savage
Journal:  Nature       Date:  2014-11-27       Impact factor: 49.962

5.  Strict 3' splice site sequence requirements for U2 snRNP recruitment after U2AF binding underlie a genetic defect leading to autoimmune disease.

Authors:  Anna Corrionero; Veronica A Raker; José María Izquierdo; Juan Valcárcel
Journal:  RNA       Date:  2011-01-13       Impact factor: 4.942

Review 6.  Delineating the Hemostaseome as an aid to individualize the analysis of the hereditary basis of thrombotic and bleeding disorders.

Authors:  Kim Fechtel; Marika L Osterbur; Hildegard Kehrer-Sawatzki; Peter D Stenson; David N Cooper
Journal:  Hum Genet       Date:  2011-05-03       Impact factor: 4.132

7.  Very early onset inflammatory bowel disease associated with aberrant trafficking of IL-10R1 and cure by T cell replete haploidentical bone marrow transplantation.

Authors:  Dhaarini Murugan; Michael H Albert; Jörg Langemeier; Jens Bohne; Jacek Puchalka; Päivi M Järvinen; Fabian Hauck; Anne K Klenk; Christine Prell; Stephanie Schatz; Jana Diestelhorst; Barbara Sciskala; Naschla Kohistani; Bernd H Belohradsky; Susanna Müller; Thomas Kirchner; Mark R Walter; Philip Bufler; Aleixo M Muise; Scott B Snapper; Sibylle Koletzko; Christoph Klein; Daniel Kotlarz
Journal:  J Clin Immunol       Date:  2014-02-12       Impact factor: 8.317

8.  Balance between short and long isoforms of cFLIP regulates Fas-mediated apoptosis in vivo.

Authors:  Daniel R Ram; Vladimir Ilyukha; Tatyana Volkova; Anton Buzdin; Albert Tai; Irina Smirnova; Alexander Poltorak
Journal:  Proc Natl Acad Sci U S A       Date:  2016-01-21       Impact factor: 11.205

Review 9.  Molecular approaches for improved clotting factors for hemophilia.

Authors:  Randal J Kaufman; Jerry S Powell
Journal:  Blood       Date:  2013-09-24       Impact factor: 22.113

Review 10.  Haemophilia.

Authors:  Erik Berntorp; Kathelijn Fischer; Daniel P Hart; Maria Elisa Mancuso; David Stephensen; Amy D Shapiro; Victor Blanchette
Journal:  Nat Rev Dis Primers       Date:  2021-06-24       Impact factor: 52.329

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.